Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB 80101 (Alliance)
- Citation:
- Pharmacogenet Genomics vol 31 (9) 215-220
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 2269
- Children:
- None
- Pharmas:
- Grants:
- U10 CA180821, U10 CA180882, U24 CA196171, U01GM61390, U01GM61393, U01GM63440; U10CA031983, U10CA060138, UG1CA233160, UG1CA233180, UG1CA233253, UG1CA233327, UG1CA233337, UG1CA233373, U10CA180857; U10CA180863 (CCTG); U10CA180868 (NRG Oncology/RTOG); U10CA180820 (ECOG-ACRIN); and U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Jai N. Patel Chen Jiang Kouros Owzar Flora Mulkey Jasmine A. Luzum Harvey J. Mamon Daniel G. Haller Tomislav Dragovich Steven R. Alberts Georg Bjarnason Christopher G. Willet Donna Niedzwiecki Peter Enzinger Mark J. Ratain Charles Fuchs Howard L. McLeod
- Networks:
- FL003, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, NC002
- Study
- CALGB-80101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- pharmacogenetic, gastric, cancer, polymorphism, gene, toxicity